BL BIOLYTICAL Trademark

Trademark Overview

On Monday, March 28, 2005, a trademark application was filed for BL BIOLYTICAL with the United States Patent and Trademark Office. The USPTO has given the BL BIOLYTICAL trademark a serial number of 78596264. The federal status of this trademark filing is REGISTERED AND RENEWED as of Sunday, June 10, 2018. This trademark is owned by BioLytical Laboratories Inc.. The BL BIOLYTICAL trademark is filed in the Pharmaceutical Products category with the following description:

In vitro diagnostic test kits comprising of reagents and instructions for detection of the presence of antibodies against Human Immunodeficiency Viruses (HIV)
bl biolytical

General Information

Serial Number78596264
Word MarkBL BIOLYTICAL
Filing DateMonday, March 28, 2005
Status800 - REGISTERED AND RENEWED
Status DateSunday, June 10, 2018
Registration Number3440596
Registration DateTuesday, June 3, 2008
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 28, 2007

Trademark Statements

Description of MarkThe mark consists of in part, a stylized representation of the letter "b" and the letter "L" combined within a circle.
Goods and ServicesIn vitro diagnostic test kits comprising of reagents and instructions for detection of the presence of antibodies against Human Immunodeficiency Viruses (HIV)
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 1, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioLytical Laboratories Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRichmond, British Columbia V6V2A2
CA
Party NameBioLytical Laboratories Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRichmond, British Columbia V6V 2X7
CA
Party NameBioLytical Laboratories Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRichmond, British Columbia V6V 2X7
CA

Trademark Events

Event DateEvent Description
Friday, May 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 18, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, June 10, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sunday, June 10, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sunday, June 10, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sunday, June 10, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 31, 2018TEAS SECTION 8 & 9 RECEIVED
Saturday, June 3, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, March 24, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 24, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 21, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 21, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 8, 2013NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED
Thursday, August 8, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, July 22, 2013REGISTERED - SEC. 8 (6-YR) FILED
Thursday, August 8, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 22, 2013PAPER RECEIVED
Tuesday, June 3, 2008REGISTERED-PRINCIPAL REGISTER
Monday, April 28, 20081(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, April 23, 2008NOTICE OF ALLOWANCE CANCELLED
Wednesday, April 23, 2008TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, November 20, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 28, 2007PUBLISHED FOR OPPOSITION
Wednesday, August 8, 2007NOTICE OF PUBLICATION
Tuesday, July 24, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 24, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 23, 2007EXAMINER'S AMENDMENT ENTERED
Thursday, July 19, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 19, 2007EXAMINERS AMENDMENT E-MAILED
Thursday, July 19, 2007EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 10, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 10, 2007NON-FINAL ACTION E-MAILED
Tuesday, July 10, 2007NON-FINAL ACTION WRITTEN
Tuesday, July 3, 2007EXAMINER'S AMENDMENT ENTERED
Friday, June 29, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 29, 2007EXAMINERS AMENDMENT E-MAILED
Friday, June 29, 2007EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 17, 2007NON-FINAL ACTION E-MAILED
Wednesday, January 17, 2007NON-FINAL ACTION WRITTEN
Wednesday, January 17, 2007AMENDMENT FROM APPLICANT ENTERED
Wednesday, January 17, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 17, 2007ASSIGNED TO LIE
Friday, December 15, 2006PAPER RECEIVED
Saturday, December 2, 2006INQUIRY TO SUSPENSION E-MAILED
Saturday, December 2, 2006SUSPENSION INQUIRY WRITTEN
Wednesday, May 31, 2006LETTER OF SUSPENSION E-MAILED
Wednesday, May 31, 2006SUSPENSION LETTER WRITTEN
Wednesday, May 31, 2006AMENDMENT FROM APPLICANT ENTERED
Thursday, April 27, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 27, 2006PAPER RECEIVED
Monday, October 24, 2005NON-FINAL ACTION E-MAILED
Monday, October 24, 2005NON-FINAL ACTION WRITTEN
Saturday, October 22, 2005ASSIGNED TO EXAMINER
Friday, April 1, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

biolytical antibodies presence against human viruses immunodeficiency detection instructions test diagnostic